Pre-transplant treatment of large polycystic kidney
نویسندگان
چکیده
منابع مشابه
Autosomal dominant polycystic kidney disease in a kidney transplant population.
AIM To define specific manifestations of autosomal dominant polycystic kidney disease in kidney transplant patients. METHODS Of 874 consecutive first renal transplant patients 1985-1993, 114 (13%) had autosomal dominant polycystic kidney disease (ADPKD). Mean age was 53 +/- 8 years, 62% were men, and 83% received cadaveric kidneys. Control patients were matched for sex, age and donor type. Me...
متن کاملAssociations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients.
BACKGROUND Delayed graft function (DGF) complicates kidney allograft outcomes in the immediate post-transplantation period. We hypothesized that in hemodialysis patients more severe anemia, iron deficiency, the requirement for higher doses of erythropoietin-stimulating agents (ESA), or blood transfusions prior to transplantation are associated with higher risk of DGF. METHODS Linking five-yr ...
متن کاملAquaretic treatment in polycystic kidney disease.
n engl j med 367;25 nejm.org december 20, 2012 2440 create an imbalance in the cytokine network, thereby driving or unmasking previously uncommon complications. The occurrence of pulmonary hypertension in one patient who received canakinumab and in two who received tocilizumab is notable, in light of a recent report of a significantly increased frequency of pulmonary hypertension in children wi...
متن کاملPre-transplant predictors of cerebrovascular events after kidney transplantation.
BACKGROUND We evaluated cerebrovascular events (CVE) after kidney transplantation (KTx) and sought to identify pre-transplant predictors of transient ischaemic attacks (TIA) and strokes post-transplantation. METHODS A total of 1617 consecutive kidney and 16 kidney-pancreas recipients transplanted between 1995 and 2005 were analysed in this retrospective single-centre study. Risk factors for C...
متن کاملThe kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
Liver disease secondary to chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in dialysis patients and kidney transplant recipients. Evaluation of patients with chronic HCV infection is warranted to determine stage of disease and the need for HCV therapy. Although combination therapy with interferon (IFN) plus ribavirin is the standard of care for chronic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Clinical Urology
سال: 2016
ISSN: 2219-2816
DOI: 10.5410/wjcu.v5.i1.66